Shares in Aston Martin plummeted by 20% as new CEO Adrian Hallmark announced a 14% cut in car production targets, attributing it to supply chain disruptions and economic challenges in China, leading to a projected lack of cash flow in the second half of 2024. The luxury carmaker’s high debt level poses a significant problem, potentially hindering future financing, although its high price point may offer some protection. Other car manufacturers, like Stellantis and Volkswagen, are also facing profit declines due to supply chain issues and decreased demand in China, leading to concerns about market share loss and potential policy interventions to address carbon emissions targets.
Full Article
3 Monster Stocks in the Making to Buy Right Now
Investors looking for potential "monster stocks" should consider the biotech sector, which offers promising early-stage companies. Three Motley Fool contributors highlight CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) as stocks with significant growth potential. Explain It To Me Like I'm 5: Some smart people think there are special companies that make medicine, called biotech stocks, and they believe that CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics could become really...
Read more